| For: | Lombardo E, Poll TVD, DelaRosa O, Dalemans W. Mesenchymal stem cells as a therapeutic tool to treat sepsis. World J Stem Cells 2015; 7(2): 368-379 [PMID: 25815121 DOI: 10.4252/wjsc.v7.i2.368] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v7/i2/368.htm |
| Number | Citing Articles |
| 1 |
P-Y Chang, Y-Q Qu, J Wang, L-H Dong. The potential of mesenchymal stem cells in the management of radiation enteropathy. Cell Death & Disease 2015; 6(8) doi: 10.1038/cddis.2015.189
|
| 2 |
Pasquale Marrazzo, Annunziata Nancy Crupi, Francesco Alviano, Laura Teodori, Laura Bonsi. Exploring the roles of MSCs in infections: focus on bacterial diseases. Journal of Molecular Medicine 2019; 97(4) doi: 10.1007/s00109-019-01752-6
|
| 3 |
Pierre-François Laterre, Miguel Sánchez-García, Tom van der Poll, Olga de la Rosa, Kathy-Ann Cadogan, Eleuterio Lombardo, Bruno François. A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit. BMC Pulmonary Medicine 2020; 20(1) doi: 10.1186/s12890-020-01324-2
|
| 4 |
|
| 5 |
Desiree Perlee, Alex F. Vos, Brendon P. Scicluna, Pablo Mancheño, Olga Rosa, Wilfried Dalemans, Peter Nürnberg, Eleuterio Lombardo, Tom Poll. Human Adipose-Derived Mesenchymal Stem Cells Modify Lung Immunity and Improve Antibacterial Defense in Pneumosepsis Caused byKlebsiella pneumoniae. Stem Cells Translational Medicine 2019; 8(8) doi: 10.1002/sctm.18-0260
|
| 6 |
William Bernal, Constantine Karvellas, Faouzi Saliba, Fuat H. Saner, Philippe Meersseman. Intensive care management of acute-on-chronic liver failure. Journal of Hepatology 2021; 75 doi: 10.1016/j.jhep.2020.10.024
|
| 7 |
Aitor Gonzaga, Gema Martinez-Navarrete, Loreto Macia, Marga Anton-Bonete, Gladys Cahuana, Juan R. Tejedo, Vanessa Zorrilla-Muñoz, Eduardo Fernandez-Jover, Etelvina Andreu, Cristina Eguizabal, Antonio Pérez-Martínez, Carlos Solano, Luis Manuel Hernández-Blasco, Bernat Soria. Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients. Biomedicines 2025; 13(8) doi: 10.3390/biomedicines13081801
|
| 8 |
Claudia G. Cárdenas-León, Kristina Mäemets-Allas, Kati Kuuse, Luis A. Salazar-Olivo, Viljar Jaks. Enhanced proliferative capacity of human preadipocytes achieved by an optimized cultivating method that induces transient activity of hTERT. Biochemical and Biophysical Research Communications 2020; 529(2) doi: 10.1016/j.bbrc.2020.06.019
|
| 9 |
Sushma Chaubey, Vineet Bhandari. Stem cells in neonatal diseases: An overview. Seminars in Fetal and Neonatal Medicine 2022; 27(1) doi: 10.1016/j.siny.2022.101325
|
| 10 |
Stephen R. Gorfine. The ASCRS Textbook of Colon and Rectal Surgery. 2016; doi: 10.1007/978-3-319-25970-3_48
|
| 11 |
Arezou Khosrojerdi, Sara Soudi, Ahmad Zavaran Hosseini, Sahar Ghaffari Khaligh, Seyed Mahmoud Hashemi. The combination of mesenchymal stem cell- and hepatocyte-derived exosomes, along with imipenem, ameliorates inflammatory responses and liver damage in a sepsis mouse model. Life Sciences 2023; 326 doi: 10.1016/j.lfs.2023.121813
|
| 12 |
Dongdong Ti, Haojie Hao, Chuan Tong, Jiejie Liu, Liang Dong, Jingxi Zheng, Yali Zhao, Huiling Liu, Xiaobing Fu, Weidong Han. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0642-6
|
| 13 |
Kui Li, Tao Wang, Rui Li, Fulai Xue, Guodan Zeng, Jingyao Zhang, Yuan Ma, Li Feng, Y. James Kang. Dose-specific efficacy of adipose-derived mesenchymal stem cells in septic mice. Stem Cell Research & Therapy 2023; 14(1) doi: 10.1186/s13287-023-03253-3
|
| 14 |
Yaru Liu, Duanyang Li, Tianyi Zhang, Keruo Wang, Xue Liang, Xiaolong Zong, Hong Yang, Zhenyu Li. Effect of imatinib on lipopolysaccharide‑induced acute lung injury and endothelial dysfunction through the P38 MAPK and NF-κB signaling pathways in vivo and in vitro. Respiratory Physiology & Neurobiology 2025; 333 doi: 10.1016/j.resp.2024.104388
|
| 15 |
Mahboube Bahroudi, Bita Bakhshi, Sara Soudi, Shahin Najar-peerayeh. Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02622-0
|
| 16 |
Ruichao Niu, Pinhua Pan, Chonghui Li, Baihua Luo, Hua Ma, Haojie Hao, Zhigang Zhao, Hang Yang, Shiyang Ma, Fei Zhu, Jie Chen. Bone mesenchymal stromal cell-derived small extracellular vesicles inhibit inflammation and ameliorate sepsis via delivery of microRNA-21a-5p. Cytotherapy 2023; 25(6) doi: 10.1016/j.jcyt.2023.02.002
|
| 17 |
Benjamin Smith, Ian R. Sigal, Daniel A. Grande. Immunology and cartilage regeneration. Immunologic Research 2015; 63(1-3) doi: 10.1007/s12026-015-8720-7
|
| 18 |
Fateme Eshghi, Safa Tahmasebi, Mina Alimohammadi, Sara Soudi, Sahar Ghaffari Khaligh, Arezou Khosrojerdi, Neda Heidari, Seyed Mahmoud Hashemi. Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation. Life Sciences 2022; 310 doi: 10.1016/j.lfs.2022.120938
|
| 19 |
Orhan Rasid, Jean-Marc Cavaillon. Recent Developments in Severe Sepsis Research: From Bench to Bedside and Back. Future Microbiology 2016; 11(2) doi: 10.2217/fmb.15.133
|
| 20 |
Philippe Hernigou, Arnaud Dubory, Yasuhiro Homma, Charles Henri Flouzat Lachaniette, Nathalie Chevallier, Helene Rouard. Single-stage treatment of infected tibial non-unions and osteomyelitis with bone marrow granulocytes precursors protecting bone graft. International Orthopaedics 2018; 42(10) doi: 10.1007/s00264-017-3687-8
|
| 21 |
Amy L. Lightner, Damián García-Olmo. Mesenchymal Stem Cell Therapy Can Transcend Perianal Crohn’s Disease: How Colorectal Surgeons Can Help in the Coronavirus Disease 2019 Crisis. Diseases of the Colon & Rectum 2020; 63(7) doi: 10.1097/DCR.0000000000001700
|
| 22 |
Jordi Rello, Antonio Perez. Precision medicine for the treatment of severe pneumonia in intensive care. Expert Review of Respiratory Medicine 2016; 10(3) doi: 10.1586/17476348.2016.1144477
|
| 23 |
K. Nemeth. Mesenchymal Stromal Cells as Tumor Stromal Modulators. 2017; doi: 10.1016/B978-0-12-803102-5.00018-5
|
| 24 |
Kirill Goryunov, Mikhail Ivanov, Andrey Kulikov, Yulia Shevtsova, Artem Burov, Yulia Podurovskaya, Victor Zubkov, Dmitry Degtyarev, Gennady Sukhikh, Denis Silachev. A Review of the Use of Extracellular Vesicles in the Treatment of Neonatal Diseases: Current State and Problems with Translation to the Clinic. International Journal of Molecular Sciences 2024; 25(5) doi: 10.3390/ijms25052879
|
| 25 |
В. Б. Москальов. ПЕРСПЕКТИВИ ВИКОРИСТАННЯ ЕКЗОМЕТАБОЛІТІВ МЕЗЕНХІМАЛЬНИХ СТОВБУРОВИХ КЛІТИН ЯК ПРОТИМІКРОБНИХ ЗАСОБІВ. Біорізноманіття, екологія та експериментальна біологія 2023; 25(1) doi: 10.34142/2708-5848.2023.25.1.03
|
| 26 |
Pierre-François Laterre, Miguel Sánchez García, Tom van der Poll, Xavier Wittebole, Fernando Martínez-Sagasti, Gonzalo Hernandez, Ricard Ferrer, Jesus Caballero, Kathy-Ann Cadogan, Adam Sullivan, Barbara Zhang, Olga de la Rosa, Eleuterio Lombardo, Bruno François. The safety and efficacy of stem cells for the treatment of severe community-acquired bacterial pneumonia: A randomized clinical trial. Journal of Critical Care 2024; 79 doi: 10.1016/j.jcrc.2023.154446
|
| 27 |
Feng Liu, Haibo Qiu, Ming Xue, Shi Zhang, Xiwen Zhang, Jingyuan Xu, Jianxiao Chen, Yi Yang, Jianfeng Xie. MSC-secreted TGF-β regulates lipopolysaccharide-stimulated macrophage M2-like polarization via the Akt/FoxO1 pathway. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1447-y
|
| 28 |
S. Manoj Kumar Kingsley, B. Vishnu Bhat. Could stem cells be the future therapy for sepsis?. Blood Reviews 2016; 30(6) doi: 10.1016/j.blre.2016.05.004
|
| 29 |
Kyong-Su Park, Kristina Svennerholm, Ganesh V. Shelke, Elga Bandeira, Cecilia Lässer, Su Chul Jang, Rakesh Chandode, Inta Gribonika, Jan Lötvall. Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10. Stem Cell Research & Therapy 2019; 10(1) doi: 10.1186/s13287-019-1352-4
|
| 30 |
Christian Lehmann, Juan Zhou, Charles C. Caldwell. Sepsis: Staging and Potential Future Therapies. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2017; 9(4) doi: 10.4199/C00157ED1V01Y201708ISP077
|
| 31 |
Zeinab Zarei-Behjani, Masoud Soleimani, Amir Atashi, Somayeh Ebrahimi-Barough, Jafar Ai, Amir Ali Hamidieh. Tracking of GFP-labeled unrestricted somatic stem cells transplanted in the sepsis mouse model. Tissue and Cell 2019; 60 doi: 10.1016/j.tice.2019.07.009
|
| 32 |
Dalia Medhat, Clara I. Rodríguez, Arantza Infante. Immunomodulatory Effects of MSCs in Bone Healing. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215467
|
| 33 |
Amandda Évelin Silva-Carvalho, Marlon Henrique Cardoso, Thuany Alencar-Silva, Gabriela Muller Reche Bogéa, Juliana Lott Carvalho, Octávio Luiz Franco, Felipe Saldanha-Araujo. Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells. Pharmacology & Therapeutics 2022; 233 doi: 10.1016/j.pharmthera.2021.108021
|
| 34 |
Courtney Premer, Joshua M. Hare, Sarah Y. Yuan, Jason W. Wilson. Mesenchymal stem/stromal cells as a therapeutic for sepsis: a review on where do we stand?. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04371-w
|
| 35 |
Diksha Gakhar, Himanshu Joshi, Diksha Makkar, Neelam Taneja, Amit Arora, Aruna Rakha. Machine learning reveals the rules governing the efficacy of mesenchymal stromal cells in septic preclinical models. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03873-3
|
| 36 |
Stephanie M. Kronstadt, Alex E. Pottash, Daniel Levy, Sheng Wang, Wei Chao, Steven M. Jay. Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment. Advanced Therapeutics 2021; 4(7) doi: 10.1002/adtp.202000259
|
| 37 |
Mohammad Mehdi Soltan Dallal, Maryam Siavashi, Samira Karimaei, Vahid Siavashi, Milad Abdi, Mehdi Yaseri, Seyed Alireza Razavi, Ronak Bakhtiari. The effect of thyme essential oil and endothelial progenitor stem cells on lipopolysaccharide‐induced sepsis in C57BL/6 mice. Biotechnology and Applied Biochemistry 2024; 71(4) doi: 10.1002/bab.2580
|
| 38 |
Haojiang Li, Shi Shen, Haitao Fu, Zhenyong Wang, Xu Li, Xiang Sui, Mei Yuan, Shuyun Liu, Guiqin Wang, Quanyi Guo. Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering. Stem Cells International 2019; 2019 doi: 10.1155/2019/9671206
|
| 39 |
Maciej Kabat, Ivan Bobkov, Suneel Kumar, Martin Grumet. Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?. Stem Cells Translational Medicine 2020; 9(1) doi: 10.1002/sctm.19-0202
|
| 40 |
Feyza İzci, Zeynep Ture, Gokcen Dinc, Arzu Hanım Yay, Esma Eryılmaz Eren, Demet Bolat, Zeynep Burcin Gönen, Gamze Kalın Ünüvar, Orhan Yıldız, Bilgehan Aygen. The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model. European Journal of Clinical Microbiology & Infectious Diseases 2023; 42(11) doi: 10.1007/s10096-023-04674-x
|
| 41 |
Wenchao Li, Weiwei Chen, Saisai Huang, Genhong Yao, Xiaojun Tang, Lingyun Sun. Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells. Clinical & Translational Immunology 2020; 9(10) doi: 10.1002/cti2.1181
|
| 42 |
Éva Mezey, Krisztián Nemeth. Mesenchymal stem cells and infectious diseases: Smarter than drugs. Immunology Letters 2015; 168(2) doi: 10.1016/j.imlet.2015.05.020
|
| 43 |
Yuxian Song, Huan Dou, Xiujun Li, Xiaoyin Zhao, Yi Li, Dan Liu, Jianjian Ji, Fei Liu, Liang Ding, Yanhong Ni, Yayi Hou. Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis. Stem Cells 2017; 35(5) doi: 10.1002/stem.2564
|
| 44 |
Philippe Vignon, Pierre-François Laterre, Thomas Daix, Bruno François. New Agents in Development for Sepsis: Any Reason for Hope?. Drugs 2020; 80(17) doi: 10.1007/s40265-020-01402-z
|
| 45 |
Dongxuan Chi, Ying Chen, Chengang Xiang, Weijian Yao, Hui Wang, Xizi Zheng, Damin Xu, Nan Li, Min Xie, Suxia Wang, Gang Liu, Shuangling Li, Li Yang. Human Amnion Epithelial Cells and Their Derived Exosomes Alleviate Sepsis-Associated Acute Kidney Injury via Mitigating Endothelial Dysfunction. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.829606
|
| 46 |
Chikkamenahalli Lakshminarayana Lakshmikanth, Shancy Petsel Jacob, Vyala Hanumanthareddy Chaithra, Hugo Caire de Castro-Faria-Neto, Gopal Kedihithlu Marathe. Sepsis: in search of cure. Inflammation Research 2016; 65(8) doi: 10.1007/s00011-016-0937-y
|
| 47 |
Robert A. F. M. Chamuleau, Ruurdtje Hoekstra. End-stage liver failure: filling the treatment gap at the intensive care unit. Journal of Artificial Organs 2020; 23(2) doi: 10.1007/s10047-019-01133-3
|
| 48 |
Arshad Khan, Chinnaswamy Jagannath. Tuberculosis Host-Pathogen Interactions. 2019; doi: 10.1007/978-3-030-25381-3_5
|
| 49 |
Özlem Öz Gergin, Sibel Seckin Pehlivan, Menekse Ulger, Ozge Cengiz Mat, Adnan Bayram, Zeynep Burçin Gönen, Nur Seda Gökdemir, Cihangir Biçer, Karamehmet Yildiz, Arzu Hanım Yay. Efficacy of stem cell-based therapies for colistin-induced nephrotoxicity. Environmental Toxicology and Pharmacology 2022; 94 doi: 10.1016/j.etap.2022.103933
|
| 50 |
Mansoor Kodori, Nima Farhadi, Gholam Ali Jafari, Hamed Afkhami, Mohammad Hasan Yousefi. Exploring mesenchymal stem cells as a novel therapeutic approach for HACEK endocarditis: a narrative review. Journal of Cardiothoracic Surgery 2026; 21(1) doi: 10.1186/s13019-026-03847-x
|
| 51 |
Desiree Perlee, Lonneke A. van Vught, Brendon P. Scicluna, Anja Maag, René Lutter, Elles M. Kemper, Cornelis van ‘t Veer, Marie A. Punchard, Jesús González, Marie Paule Richard, Wilfried Dalemans, Eleuterio Lombardo, Alex F. de Vos, Tom van der Poll. Intravenous Infusion of Human Adipose Mesenchymal Stem Cells Modifies the Host Response to Lipopolysaccharide in Humans: A Randomized, Single-Blind, Parallel Group, Placebo Controlled Trial. Stem Cells 2018; 36(11) doi: 10.1002/stem.2891
|
| 52 |
Hongyu Zhang, Yan Sun, Yongjun Tang, Lidan Yao, Xiherezhati Abulimiti, Qinfen Wu. Astragaloside II-preconditioned bone marrow mesenchymal stem cells attenuate sepsis-induced acute lung injury by restoring mitochondrial function via NRF2/PGC-1α pathway activation. Biochemical and Biophysical Research Communications 2026; 829 doi: 10.1016/j.bbrc.2026.154148
|
| 53 |
Shujun Yang, Kanglong Zhang, Jingyu Hou, Xin Liu, Daishi Xu, Xuxiang Chen, Shuangmei Li, Yinghui Hong, Changqing Zhou, Hao Wu, Guanghui Zheng, Chaotao Zeng, Haidong Wu, Jiaying Fu, Tong Wang. Protective properties of extracellular vesicles in sepsis models: a systematic review and meta-analysis of preclinical studies. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04121-7
|
| 54 |
Andrea Papait, Anna Cargnoni, Michal Sheleg, Antonietta R. Silini, Gilad Kunis, Racheli Ofir, Ornella Parolini. Perinatal Cells: A Promising COVID-19 Therapy?. Frontiers in Bioengineering and Biotechnology 2021; 8 doi: 10.3389/fbioe.2020.619980
|
| 55 |
Amir Hossein Aghayan, Yasin Mirazimi, Leila Nasehi, Amir Atashi. The toxic effects of neutrophil extracellular traps on mesenchymal stem cells. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-024-10134-2
|
| 56 |
Francisca Alcayaga-Miranda, Jimena Cuenca, Aldo Martin, Luis Contreras, Fernando E. Figueroa, Maroun Khoury. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis. Stem Cell Research & Therapy 2015; 6(1) doi: 10.1186/s13287-015-0192-0
|
| 57 |
Adeline Castro Ramos, Markus Yovian Widjaja Lomanto, Cat-Khanh Vuong, Osamu Ohneda, Mizuho Fukushige. Antibacterial effects of human mesenchymal stem cells and their derivatives: a systematic review. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1430650
|
| 58 |
Anne George, Sriram Ravindran. Magnetic Resonance Imaging in Tissue Engineering. 2017; doi: 10.1002/9781119193272.ch11
|
| 59 |
Fernanda F. Cruz, Daniel J. Weiss, Patricia R. M. Rocco. Prospects and progress in cell therapy for acute respiratory distress syndrome. Expert Opinion on Biological Therapy 2016; 16(11) doi: 10.1080/14712598.2016.1218845
|
| 60 |
Mohammad Saeedi, Muhammad S. Nezhad, Fatemeh Mehranfar, Mahdieh Golpour, Mohammad A. Esakandari, Zahra Rashmeie, Maryam Ghorbani, Fatemeh Nasimi, Seyed N. Hoseinian. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to be Aware of. Current Pharmaceutical Biotechnology 2021; 22(2) doi: 10.2174/1389201021666200907121530
|
| 61 |
F. F. Cruz, P. R. M. Rocco, P. Pelosi. Annual Update in Intensive Care and Emergency Medicine 2021. Annual Update in Intensive Care and Emergency Medicine 2021; doi: 10.1007/978-3-030-73231-8_17
|
| 62 |
Erling Hu, Liang Ding, Huishuang Miao, Fei Liu, Dan Liu, Huan Dou, Yayi Hou. MiR‐30a attenuates immunosuppressive functions of IL‐1β‐elicited mesenchymal stem cells via targeting TAB3. FEBS Letters 2015; 589(24PartB) doi: 10.1016/j.febslet.2015.11.001
|
| 63 |
Suneel Kumar, Maciej Kabat, Sayantani Basak, Joanne Babiarz, Francois Berthiaume, Martin Grumet. Anti-Inflammatory Effects of Encapsulated Human Mesenchymal Stromal/Stem Cells and a Method to Scale-Up Cell Encapsulation. Biomolecules 2022; 12(12) doi: 10.3390/biom12121803
|
| 64 |
Khan Maliha, Adil Syeda Ezze Rukhshan, Olson Amanda L. The role of mesenchymal stem cells in oncology and regenerative medicine. Future Oncology 2017; 13(9) doi: 10.2217/fon-2016-0264
|
| 65 |
Wei Zhou, Yi Chen, Xingyu Zhang. Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability. Medical Science Monitor 2017; 23 doi: 10.12659/MSM.899618
|
| 66 |
Joyce Carvalho Pereira, Tadeu Diniz Ramos, Johnatas Dutra Silva, Mirian França de Mello, Juliana Elena Silveira Pratti, Alessandra Marcia da Fonseca-Martins, Luan Firmino-Cruz, Jamil Zola Kitoko, Suzana Passos Chaves, Daniel Claudio De Oliveira Gomes, Bruno Lourenço Diaz, Patricia R. M. Rocco, Herbert Leonel de Matos Guedes. Effects of Bone Marrow Mesenchymal Stromal Cell Therapy in Experimental Cutaneous Leishmaniasis in BALB/c Mice Induced by Leishmania amazonensis. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00893
|
| 67 |
Elena Santacroce, Miriam D’Angerio, Alin Liviu Ciobanu, Linda Masini, Domenico Lo Tartaro, Irene Coloretti, Stefano Busani, Ignacio Rubio, Marianna Meschiari, Erica Franceschini, Cristina Mussini, Massimo Girardis, Lara Gibellini, Andrea Cossarizza, Sara De Biasi. Advances and Challenges in Sepsis Management: Modern Tools and Future Directions. Cells 2024; 13(5) doi: 10.3390/cells13050439
|
| 68 |
Khalid A Al-Anazi, Rehab Y Al-Ansari. Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection. Journal of Stem Cell Therapy and Transplantation 2023; 7(1) doi: 10.29328/journal.jsctt.1001033
|
| 69 |
Gloria Pelizzo, Maria A. Avanzini, Elisa Lenta, Melissa Mantelli, Stefania Croce, Laura Catenacci, Gloria Acquafredda, Aurelio L. Ferraro, Caterina Giambanco, Lucia D'Amelio, Salvatore Giordano, Giuseppe Re, Floriana Zennaro, Valeria Calcaterra. Allogeneic mesenchymal stromal cells: Novel therapeutic option for mutated FLNA‐associated respiratory failure in the pediatric setting. Pediatric Pulmonology 2020; 55(1) doi: 10.1002/ppul.24497
|
| 70 |
Fethi GUL, Deniz GENC, Mustafa Kemal ARSLANTAS, Noushin ZIBANDEH, Leyla TOPCU, Tunç AKKOC, İsmail CINEL. Dental follicle mesenchymal stem cells regulate responses in sepsis. Marmara Medical Journal 2020; 33(1) doi: 10.5472/marumj.681996
|
| 71 |
Fereshteh Radmanesh, Mahmoud Mahmoudi, Esmaeil Yazdanpanah, Vahideh Keyvani, Nadia Kia, Amin Reza Nikpoor, Parisa Zafari, Seyed‐Alireza Esmaeili. The immunomodulatory effects of mesenchymal stromal cell‐based therapy in human and animal models of systemic lupus erythematosus. IUBMB Life 2020; 72(11) doi: 10.1002/iub.2387
|
| 72 |
Tahereh Rostami, Nasrollah Maleki, Amir Kasaeian, Mohsen Nikbakht, Azadeh Kiumarsi, Seyed Asadollah Mousavi, Ardeshir Ghavamzadeh. Co‐transplantation of bone marrow‐derived mesenchymal stem cells with hematopoietic stem cells does not improve transplantation outcome in class III beta‐thalassemia major: A prospective cohort study with long‐term follow‐up. Pediatric Transplantation 2021; 25(3) doi: 10.1111/petr.13905
|
| 73 |
Omnia S. Zaki, Marwa M. Safar, Afaf A. Ain-Shoka, Laila A. Rashed. A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway. Inflammation 2018; 41(1) doi: 10.1007/s10753-017-0659-5
|
| 74 |
Jordi Rello, Eleonora Bunsow, Antonio Perez. What if there were no new antibiotics? A look at alternatives. Expert Review of Clinical Pharmacology 2016; 9(12) doi: 10.1080/17512433.2016.1241141
|
| 75 |
Alvaro Avivar-Valderas, Cristina Martín-Martín, Cristina Ramírez, Borja Del Río, Ramón Menta, Pablo Mancheño-Corvo, Maitane Ortiz-Virumbrales, Ángel Herrero-Méndez, Julián Panés, Damián García-Olmo, José Luís Castañer, Itziar Palacios, Eleuterio Lombardo, Wilfried Dalemans, Olga DelaRosa. Dissecting Allo-Sensitization After Local Administration of Human Allogeneic Adipose Mesenchymal Stem Cells in Perianal Fistulas of Crohn's Disease Patients. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01244
|
| 76 |
Parisa Afzal Haghjoo, Ali Mojtahedi, Malek Moien Ansar, Malek Masoud Ansar, Safieh Danesh Mobarhan, Christian Agyare. The antibacterial effect of human adipose-derived stem cells on LL-37-resistant bacteria. PLOS One 2025; 20(10) doi: 10.1371/journal.pone.0333647
|
| 77 |
Lite Ge, Jing Zhao, Huiyin Deng, Chunli Chen, Zhiping Hu, Liuwang Zeng. Effect of Bone Marrow Mesenchymal Stromal Cell Therapies in Rodent Models of Sepsis: A Meta-Analysis. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.792098
|
| 78 |
Gokcen Dinc, Esma Eren, Olgun Kontas, Mehmet Doganay. The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(9) doi: 10.1007/s10096-020-03910-y
|
| 79 |
Sadaf Hoseinnia, Maryam Ghane, Jamile Norouzi, Farzaneh Hosseini. Mesenchymal stem cell and endothelial progenitor cells coinjection improves LPS‐induced lung injury via Tie2 activation and downregulation of the TLR4/MyD88 pathway. Journal of Cellular Biochemistry 2021; 122(12) doi: 10.1002/jcb.30133
|
| 80 |
Tadeu Diniz Ramos, Johnatas Dutra Silva, Alessandra Marcia da Fonseca-Martins, Juliana Elena da Silveira Pratti, Luan Firmino-Cruz, Diogo Maciel-Oliveira, Julio Souza Dos-Santos, João Ivo Nunes Tenorio, Almair Ferreira de Araujo, Célio Geraldo Freire-de-Lima, Bruno Lourenço Diaz, Fernanda Ferreira Cruz, Patricia Rieken Macedo Rocco, Herbert Leonel de Matos Guedes. Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01889-z
|
| 81 |
Ling Ling Liau, Maimonah Eissa Al-Masawa, Benson Koh, Qi Hao Looi, Jhi Biau Foo, Sau Har Lee, Fook Choe Cheah, Jia Xian Law. The Potential of Mesenchymal Stromal Cell as Therapy in Neonatal Diseases. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.591693
|
| 82 |
Yu Sato, Daigo Ochiai, Yushi Abe, Hirotaka Masuda, Marie Fukutake, Satoru Ikenoue, Yoshifumi Kasuga, Masayuki Shimoda, Yae Kanai, Mamoru Tanaka. Prophylactic therapy with human amniotic fluid stem cells improved survival in a rat model of lipopolysaccharide-induced neonatal sepsis through immunomodulation via aggregates with peritoneal macrophages. Stem Cell Research & Therapy 2020; 11(1) doi: 10.1186/s13287-020-01809-1
|
| 83 |
Valerie Johnson, Tracy Webb, Annalis Norman, Jonathan Coy, Jade Kurihara, Daniel Regan, Steven Dow. Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08311-4
|
| 84 |
Reconditioned monocytes are immunomodulatory and regulate inflammatory environment in sepsis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-42237-4
|
| 85 |
Leonardo Pedrazza, Talita Carneiro Brandão Pereira, Ana Lucia Abujamra, Fernanda Bordignon Nunes, Maurício Reis Bogo, Jarbas Rodrigues de Oliveira. Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis. Inflammation Research 2017; 66(7) doi: 10.1007/s00011-017-1042-6
|
| 86 |
Lauralyn A. McIntyre, Duncan J. Stewart, Shirley H. J. Mei, David Courtman, Irene Watpool, John Granton, John Marshall, Claudia dos Santos, Keith R. Walley, Brent W. Winston, Kenny Schlosser, Dean A. Fergusson. Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial. American Journal of Respiratory and Critical Care Medicine 2018; 197(3) doi: 10.1164/rccm.201705-1006OC
|